Related Experiment Video
Updated: Apr 20, 2026
07:41
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.5K
Clinical implications of chronic heart failure phenotypes defined by cluster analysis
Tariq Ahmad1, Michael J Pencina2, Phillip J Schulte2
1Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Journal of the American College of Cardiology
|December 3, 2014
Summary
This study identified four distinct heart failure phenotypes using cluster analysis, revealing significant variations in patient characteristics and outcomes. These findings highlight the need for better phenotyping to understand heart failure heterogeneity.
Area of Science:
- Cardiology
- Biostatistics
- Clinical Research
Background:
- Current chronic heart failure (HF) classification may not fully capture disease heterogeneity.
- Improved phenotyping is crucial for advancing research and therapeutic strategies in HF.
Purpose of the Study:
- To utilize cluster analysis for exploring distinct clinical phenotypes in chronic heart failure patients.
- To identify patient subgroups with varying clinical characteristics and outcomes within chronic HF.
Main Methods:
- Cluster analysis was applied to 45 baseline clinical variables from 1,619 participants in the HF-ACTION trial.
- Cox proportional hazards modeling assessed associations between identified clusters and clinical outcomes.
- Interaction testing examined differential effects of exercise on outcomes between clusters.
Main Results:
- Four distinct chronic heart failure clusters were identified, varying in demographics, comorbidities, symptoms, and biomarkers.
- Significant differences in hospitalization and mortality risks were observed across and within clusters.
- Cluster 3 showed a disproportionately lower risk for all-cause mortality, while exercise treatment effects varied by cluster.
Conclusions:
- Cluster analysis revealed 4 unique phenotypes in chronic heart failure, underscoring significant disease heterogeneity.
- The findings emphasize the necessity for enhanced phenotyping strategies in chronic heart failure management.
- Distinct patient profiles suggest potential for tailored therapeutic approaches and research.
More Related Videos
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
651
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
651
01:17Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
01:27Heart Failure I: Introduction
1.4K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
01:29Heart Failure II: Pathophysiology
1.6K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
01:26Heart Failure III: Clinical Manifestations
968
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
968